StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CannaPharmaRx's free cash flow for the twelve months ending Dec 31, 2025 was -$794.62K. For fiscal 2025 it was -$794.62K. The highest annual figure on record is -$22.38K in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$794.62K–
FY2024Dec 31, 2024-$1.70M–
FY2023Dec 31, 2023-$2.36M–
FY2022Dec 31, 2022-$1.56M–
FY2019Dec 31, 2019-$3.80M–
FY2018Dec 31, 2018-$941.14K–
FY2016Dec 31, 2016-$22.38K–
FY2015Dec 31, 2015-$2.55M–
FY2014Dec 31, 2014-$1.64M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$167.24K–
Q4 FY2025Dec 31, 2025$1.06M–
Q3 FY2025Sep 30, 2025-$802.70K–
Q4 FY2024Dec 31, 2024-$179.89K–
Q3 FY2024Sep 30, 2024-$540.90K-551.9%
Q2 FY2024Jun 30, 2024-$427.62K–
Q1 FY2024Mar 31, 2024-$548.83K–
Q4 FY2023Dec 31, 2023-$1.31M–
Q3 FY2023Sep 30, 2023$119.70K–
Q2 FY2023Jun 30, 2023-$555.98K–
Q1 FY2023Mar 31, 2023-$612.63K–
Q4 FY2022Dec 31, 2022-$1.10M–
Q4 FY2019Dec 31, 2019-$975.39K–
Q4 FY2018Dec 31, 2018-$734.89K–
Q4 FY2016Dec 31, 2016-$1–

More CannaPharmaRx figures

See a number that looks wrong?